Compared with other HDAC inhibitors, AR-42 was more potent in inducing apoptosis and suppressing tumor xenograft growth in chronic lymphocytic leukemia (CLL) cell lines [19]. This evidence concerns the gene HDAC9 and B-cell chronic lymphocytic leukemia.